It is a short introduction to our products, where innovation meets health and well-being. Explore our range of cutting-edge products meticulously crafted to enhance lives and provide effective solutions to medical challenges. With groundbreaking medications, our commitment to excellence drives us to deliver only the highest quality products. Discover how our innovations are shaping the future of healthcare and empowering individuals to lead healthier and happier lives.
Our Portfolio
Let’s delve into the comprehensive details that set our offerings apart in the realm of the pharmaceutical industry.
Oncology
PADYNEX®
PADYNEX is a targeted therapy used in the treatment of HER2-positive breast cancer. It combines a monoclonal antibody and a chemotherapy drug. This unique combination allows trastuzumab to deliver emtansine directly to the cancer cells, potentially minimizing damage to healthy tissues.
More InformationHepatology
SYPPER®
SYPPER is a medication used to treat Wilson’s disease, a rare genetic disorder that leads to the accumulation of copper in the body. It belongs to a class of drugs called chelating agents, which help remove excess copper from the body by binding to it and forming compounds that can be excreted through urine.
More InformationOncology
Palbocap®
Palbocap is a targeted cancer medication used to treat certain types of breast cancer. Its function works by blocking specific proteins involved in cell division and growth. By inhibiting these proteins, it helps slow down the progression of cancer cells, particularly in hormone receptor-positive and HER2-negative breast cancer.
More InformationOncology
TPOral®
TPOral is a medication used to treat conditions involving low platelet counts, such as immune thrombocytopenia (ITP) and chronic hepatitis C-associated thrombocytopenia. It belongs to a class of drugs called thrombopoietin receptor agonists, which stimulate the production of platelets in the bone marrow.
More InformationOncology
Paclinab®
Paclinab is used in the treatment of various types of cancer. It consists of a potent anti-cancer drug, encapsulated within nanoparticles made of albumin that allows for higher drug concentrations & improved delivery to tumor cells.
More InformationRheumatology & Orthopedics
Opijex®
Opijex is an injectable product for individuals with osteoarthritis, a condition characterized by the breakdown of cartilage in the joint. Hyaluronic acid as a naturally substance found in the synovial fluid, can lubricates and cushions the joints.
More InformationOncology
Tederox®
Psychiatrics
EXOPIO®
EXOPIO is a medication used in the management of alcohol and opioid dependence. It is a long-acting form of naltrexone, an opioid receptor antagonist that blocks the effects of opioids and reduces cravings for alcohol.
More InformationOncology
Bortezomib®
Bortezomib is used in the treatment of multiple myeloma and certain types of lymphoma. It falls under the category of drugs known as proteasome inhibitors, which work by blocking proteasomes, structures within cells that help regulate protein degradation.
More InformationOncology
Folypra®
Folypra is a chemotherapy medication used to treat a type of cancer called peripheral T-cell lymphoma. Folypra belongs to a class of drugs known as antifolates that interfere with the growth of cancer cells by inhibiting and blocking a key enzyme involved in DNA synthesis.
More InformationRheumatology & Orthopedics
Depostiva®
Depostiva is a synthetic corticosteroid that belongs to the glucocorticoid class of drugs. It’s used for anti-inflammatory & immunosuppressive properties. It is commonly prescribed to treat a range of inflammatory conditions including skin disorders, allergic reactions, and joint pain.
More InformationOncology
Pemetrexed – ND®
Pemetrexed – ND is a chemotherapy medication used to treat various types of cancer, including lung cancer and mesothelioma. It works by inhibiting enzymes essential for DNA and RNA synthesis in cancer cells, slowing their growth.
More InformationOncology
Osimertinib®
Osimertinib is a targeted therapy drug revolutionized the treatment of certain types of lung cancer. IT belongs to a class of drugs known as epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors. It is designed to inhibit the growth signals that drive tumor development.
More InformationRadiology
DotaScan®
Aesthetic
Xitritall®Hydro
Your Contribution, Your Vital Role
You can access comprehensive information and submit reports related to adverse events. Your safety and well-being are of utmost importance to us, and this platform allows us to gather valuable insights to ensure the highest standards of product and service quality. Please feel free to navigate through the provided resources and report any adverse events you may have encountered.
Get in touch With Us